Health Care & Life Sciences » Pharmaceuticals | Aeolus Pharmaceuticals Inc.

Aeolus Pharmaceuticals Inc.

Aeolus Pharmaceuticals Inc.
Stock Exchange Other OTC
EPS
$0.04
Market Cap
$182.5 K
Shares Outstanding
152.09 M
Public Float
-

Profile

Address
26361 Crown Valley Parkway
Mission Viejo California 92691
United States
Employees -
Website http://www.aolsrx.com
Updated 07/08/2019
Aeolus Pharmaceuticals, Inc. engages in the business of developing platform of broad-spectrum, catalytic antioxidant compounds that protect healthy tissue from the damaging effects of oxidative stress development of medical countermeasures against biological, chemical and radiological weapons in the U. S. It also develops medical countermeasures for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology.

Financials

View All
Created with Highcharts 5.0.14Aeolus Pharmaceuticals Inc.Net Income. Fiscal year is October-September. All values USD Thousands.1 6981 6983 2083 20880802 6282 6283 5583 5582012201320142015201601k2k3k4k
Created with Highcharts 5.0.14Aeolus Pharmaceuticals Inc.Sales/Revenue. Fiscal year is October-September. All values USD Thousands.7 2937 2933 9283 9289 6319 6313 1113 1112 0762 0762012201320142015201602.5k5k7.5k10k12.5k

David C. Cavalier
Chairman, Chief Financial Officer & Secretary
Amit Kumar
Independent Director